A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients

Metabolism: Clinical and Experimental

Volumn 62, Issue 12, 2013, Pages 1858-1866

  Yang, Yue ^a,b   Wei, Ri Bao ^a   Xing, Yue ^a   Tang, Lu ^a,b   Zheng, Xiao Yong ^a   Wang, Zi Cheng ^a   Gao, Yu Wei ^a   Li, Min Xia ^a   Chen, Xiang Mei ^a  

^a State Discipline and State Key Laboratory of Kidney Disease   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Angiotensin receptor blockers; Calcium channel blockers; Insulin resistance; Meta analysis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT;

ACEI; ADA; AMERICAN DIABETES ASSOCIATION; ANG II INHIBITS THE ANGIOTENSIN II RECEPTOR 1; ANGIOTENSIN CONVERTING ENZYME INHIBITORS; ANGIOTENSIN RECEPTOR BLOCKER; ANGIOTENSIN RECEPTOR BLOCKERS; ARB; AT1; CALCIUM CHANNEL BLOCKER; CALCIUM CHANNEL BLOCKERS; CCB; DBP; DIASTOLIC BLOOD PRESSURE; FASTING PLASMA GLUCOSE; FASTING PLASMA INSULIN; FPG; FPI; HOMA-IR; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; IFG; IGT; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; IR; META-ANALYSIS; PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS-GAMMA; PPAR-Γ; RANDOMIZED CONTROLLED TRIALS; RAS; RCTS; RENIN-ANGIOTENSIN SYSTEM; SBP; SD; SEM; STANDARD DEVIATION; STANDARD ERROR OF THE MEAN; SYSTOLIC BLOOD PRESSURE; WEIGHTED MEAN DIFFERENCE; WMD;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84888003467     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.08.008     Document Type: Article

References (26)

1. J.I. Odegaard, and A. Chawla Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis Science 339 6116 2013 172 177
2. L.U. Monzillo, and O. Hamdy Evaluation of insulin sensitivity in clinical practice and in research settings Nutr Rev 61 12 2003 397 412
3. M.H. Park, S. Kinra, and K.J. Ward Metformin for obesity in children and adolescents: a systematic review Diabetes Care 32 9 2009 1743 1745
4. A.J. Scheen, and P.J. Lefebvre Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes Diabetes Care 22 9 1999 1568 1577
5. B. Staels, and J.C. Fruchart Therapeutic roles of peroxisome proliferator-activated receptor agonists Diabetes 54 8 2005 2460 2470
6. G. Derosa, and P. Maffioli Nifedipine and telmisartan for the treatment of hypertension: the TALENT study Expert Rev Cardiovasc Ther 9 12 2011 1499 1503
7. M. Schupp, J. Janke, and R. Clasen Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-alpha activity Circulation 109 17 2004 2054 2057
8. K. Ushijima, M. Takuma, and H. Ando Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice Eur J Pharmacol 698 1-3 2013 505 510
9. S. Julius, S.E. Kjeldsen, and M. Weber Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Lancet 363 9426 2004 2022 2031
10. K. Nakao, M. Hirata, and K. Oba Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial Hypertens Res 33 6 2010 600 606
11. T.M. Wallace, J.C. Levy, and D.R. Matthews Use and abuse of HOMA modeling Diabetes Care 27 6 2004 1487 1495
12. American Diabetes Association Standards of medical care in diabetes Diabetes Care 28 2005 S4 S36
13. J. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions version 5.0. 2 [updated September 2009]. The Cochrane Collaboration, 2009 Available from www.cochrane-handbook.org 2010
14. S.S. Wong, N.L. Wilczynski, and R.B. Haynes Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE J Med Libr Assoc 94 1 2006 41 47
15. M. Egger, G. Davey Smith, and M. Schneider Bias in meta-analysis detected by a simple, graphical test BMJ 315 7109 1997 629 634
16. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 4 1994 1088 1101
17. T.A. Aksnes, H.M. Reims, and S. Guptha Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors J Hum Hypertens 20 11 2006 860 866
18. R. Fogari, G. Derosa, and A. Zoppi Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients Hypertens Res 28 3 2005 209 214
19. T. Hinoi, Y. Tomohiro, and S. Kajiwara Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy Hypertens Res 31 4 2008 615 622
20. J. Lan, X. Chen, and S. Wang The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients with insulin resistance Diabetes Res Clin Pract 94 1 2011 71 76
21. H. Nishimura, T. Sanaka, and Y. Tanihata Losartan elevates the serum high-molecular weight-adiponectin isoform and concurrently improves insulin sensitivity in patients with impaired glucose metabolism Hypertens Res 31 8 2008 1611 1618
22. F.A. El-Atat, S.N. Stas, and S.I. McFarlane The relationship between hyperinsulinemia, hypertension and progressive renal disease J Am Soc Nephrol 15 11 2004 2816 2827
23. M.C. Blendea, D. Jacobs, and C.S. Stump Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression Am J Physiol Endocrinol Metab 288 2 2005 E353 359
24. J. Janke, S. Engeli, and K. Gorzelniak Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors Diabetes 51 6 2002 1699 1707
25. G.M. Reaven Insulin resistance may or may not play a role in blood pressure regulation J Intern Med 244 4 1998 359 360
26. E. Ferrannini, and W.C. Cushman Diabetes and hypertension: the bad companions Lancet 380 9841 2012 601 610